Records containing: Hidradenitis Suppurativa
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-03A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
-
CLINICAL_TRIALS study record update · 2026-04-01Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab in Routine Clinical Practice in the United Arab Emirates: ILLUMINATE-HS, a Prospective Patient Surve
-
CLINICAL_TRIALS study record update · 2026-03-30Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases
-
CLINICAL_TRIALS study record update · 2026-03-27A Multicenter, Open-Label Study to Assess The Pharmacokinetics And Safety of Bimekizumab in Pubertal Children And Adolescents With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-03-20A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-20A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-03-17The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
-
CLINICAL_TRIALS study record update · 2026-03-13Clinical and Biological Characteristics of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-03-13Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
-
CLINICAL_TRIALS study record update · 2026-03-12A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa. (RECHARGE-1)
-
CLINICAL_TRIALS study record update · 2026-03-11A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE-2)
-
CLINICAL_TRIALS study record update · 2026-03-09A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-03-0612 Months-observation of Patients Treated for Hidradenitis Suppurativa, With High Cardiovascular Risk or Established Coronary Plaque: A Prospective Monocentric Study - the HOPE Study
-
CLINICAL_TRIALS study record update · 2026-03-06A Bioelectric Dressing for Post De-Roofing Treatment of Hidradenitis Suppurativa (HS)
-
CLINICAL_TRIALS study record update · 2026-03-06A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-03-06A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - The CEDAR Study
-
CLINICAL_TRIALS study record update · 2026-03-05Regulatory Post-Marketing Surveillance to Assess Safety and Effectiveness in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea : a rPMS Study
-
CLINICAL_TRIALS study record update · 2026-03-04A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
-
CLINICAL_TRIALS study record update · 2026-03-04Hidradenitis Suppurativa - a Mendelian Trait? Genetic Pedigree and Linkage Analysis
-
CLINICAL_TRIALS study record update · 2026-02-27The Ohio State University Dermatology Biorepository
-
CLINICAL_TRIALS study record update · 2026-02-20A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-02-19Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures
-
CLINICAL_TRIALS study record update · 2026-02-17Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2026-02-17A Prospective Open-label Trial Examining the Efficacy and Safety of Anifrolumab for Hidradenitis Suppurativa (HS)
-
CLINICAL_TRIALS study record update · 2026-02-13Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)